RPRoman I. Pimenov

Roman I. Pimenov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roman I. Pimenov has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Experience with the use of nivolumab and ipilimumab in metastatic fibrolamellar liver carcinoma

    by E. Yu. Antonova, I. A. Dzhanyan, I. V. Savchenko, E. A. Moroz, K. K. Laktionov, K. A. Romanova, R. I. Pimenov, Е. V. Sharapova, V. V. Breder

    Fibrolamellar hepatocellular carcinoma is a rare primary liver tumor with no known risk factors, which occurs in 1–7% of cases of all hepatocellular carcinoma. The disease occurs mainly in adolescents, as an accidental finding or when symptoms appear already during the metastatic process. The main method of treatment with proven efficacy for localized fibrolamellar hepatocellular carcinoma is surgical. The experience of using radiation therapy and transarterial chemoembolization is contradictory and needs additional study. The option of preferred drug antitumor treatment is not fully clear, and the search for effective therapy regimens and potential targets specific to this form of hepatocellular carcinoma is relevant and requires further study. Considering the rarity of the pathology, the world literature presents data on the treatment of small groups of patients and clinical cases of successful use of a number of medicinal antitumor regimens. However, the data are contradictory. The literature describes isolated clinical cases of successful use of immunotherapy in patients with fibrolamellar hepatocellular carcinoma, requiring further detailed study. Using the example of this clinical case, we have shown the successful long-term use of combined immunotherapy in a patient with fibrolamellar liver carcinoma.

  • Open Access

    Prosthetics of the inferior vena cava in children with hepatoblastoma: a literature review and our own results

    by A.V. Filin, E.R. Charchyan, A.V. Metelin, T.N. Galyan, V.V. Khovrin, Yu.R. Kamalov, R.I. Pimenov, Moscow Morozov Children’s City Clinical Hospital, R.B. Mayachkin, O.V. Kazakova, et al.

    Протезирование нижней полой вены у детей с гепатобластомой: обзор литературы и собственные результаты

  • Open Access

    Treatment of children with very low-risk hepatoblastoma according to the Children’s Hepatic tumors International Collaboration classification: a series of clinical observations

    by R. I. Pimenov, P. A. Kerimov, A. P. Kazantsev, M. V. Rubanskaya, M. A. Rubanskiy, O. P. Blisnyukov, E. V. Mikhailova, S. N. Mikhailova, A. L. Nikulina, A. A. Malakhova, et al.

    Relevance. The success of treatment of children with hepatoblastoma (HB) is associated primarily with the optimization of diagnostic and therapeutic strategies. The introduction of a system of therapeutic definition of a risk group developed by the International Society for the Study of Liver Tumors in Children’s Hepatic tumors International Collaboration (CHIC) in patients with HB allows for effective risk stratification. Patients of the very low-risk group have a favorable prognosis and, unlike patients of other groups, they can perform surgery at the 1st stage, and children from the very low-risk group with a “pure” fetal version of the morphological structure of the tumor can be cured without chemotherapy – only by surgical method. This article presents an analysis of a series of observations of children with HB very low-risk.Methods and patients. A retrospective analysis of the data of 138 patients who received treatment at the Research Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Centre of Oncology of the Ministry of Health of Russia from January 2006 to February 2018, all patients underwent examination in the following volume: computed tomography (CT) of the chest, ultrasound of the abdominal cavity and retroperitoneal space, CT and/or magnetic resonance imaging of the abdominal cavity with contrast enhancement. Serum levels of human chorionic gonadotropin and alpha-fetoprotein (AFP) were measured. The prevalence of tumor lesions was retrospectively evaluated using the PRETEXT system (Pre-Treatment Extent of Disease, assessment of the prevalence of the tumor process before treatment, 2017 version). Based on the data obtained, 18 (13 %) patients with hypertension were identified in the very low-risk group using the CHIC stratification system. Of 18 (100 %) patients of the very low-risk group, 8 (44.4 %) received therapy in the interval from January 2006 to October 2010 according to the treatment protocols of the SIOPEL group. The treatment included a combination of neoadjuvant chemotherapy with delayed surgery and adjuvant chemotherapy. Since November 2010, the Research Institute of Pediatric Oncology and Hematology adopted a protocol for the treatment of children with hypertension, suggesting the possibility of performing surgical treatment at the 1 st stage in patients with a localized stage of the disease with the spread of PRETEXT I/II. From December 2010 to November 2018, 10 (55.6 %) patients from the very low-risk group were operated on at the 1 st stage. A tumor biopsy was not performed before the intervention. After a histological examination, 4 (22.2 %) patients had an epithelial variant of the structure of HB that did not meet the criteria of a “pure” fetal variant. He was given adjuvant chemotherapy according to the SIOPEL protocol. And in 6 (33.3 %) patients, according to the results of a morphological study, the HB structure variant was interpreted as a “pure” fetal variant. Further therapy in this group of patients was not performed. The analysis of the results of treatment of these 6 patients without the use of chemotherapy is presented in our article.Results. The average age of patients is 3.7 (1–6) years, the median is 3.7 ± 2.0. Boys/girls – 4:2. In all cases, there was an asymptomatic course of the disease, a neoplasm was detected by chance during an ultrasound scan. All children had an elevated AFP level in the range of 95.2–695 (286.0 ± 116.8) IU/ml. Distribution according to PRETEXT I/II – 2 (33.3 %) and 4 (66.7 %) patients, respectively. Patients did not have additional PRETEXT criteria and metastases. Surgical treatment was performed by the laparoscopic method in 2 of 6 patients. Scope of operation: right-sided hemihepatectomy – 3, left-sided – 1, bisegmentectomy – 1, atypical resection – 1. Lymphatic dissection in the area of the hepatoduodenal ligament was not performed. There were no complications of treatment and repeated surgical interventions. The radicalness of the intervention in the volume of R0 was confirmed by histological examination in all patients. Morphological examination in all cases revealed a “pure” fetal version of the structure of the tumor. All patients are alive without signs of relapse at follow-up periods of 14.7 to 59.2 (32.0 ± 18.7) months.Conclusion. Using the system of therapeutic stratification into risk groups CHIC allows you to effectively distinguish patients with very low-risk groups, and for some children with a “pure” fetal version of the histological structure of the tumor, only the surgical approach can be used for treatment. At the same time, the short observation period for the patients and their small number do not allow us to draw final conclusions and dictate the need for a multicenter study. It should be noted that this cohort of patients requires careful observance of the post-therapeutic observation algorithm.

  • Open Access

    Congenital infantile fibrosarcoma of soft tissues of the chest wall on the left (description of the clinical case and literature review)

    by G. B. Sagoyan, M. V. Rubanskaya, P. A. Kerimov, O. A. Kapkova, M. A. Rubanskiy, D. V. Shevtsov, A. M. Suleymanova, R. I. Pimenov, A. S. Temnyy, N. V. Matinyan, et al.

    Infantile fibrosarcoma (IF) is a rare soft tissue sarcoma that occurs with a frequency of 1% of all cases of malignant neoplasms in children in the first year of life. IF most often affects the soft tissues of the upper and lower extremities. Rare localizations include the trunk, the head and neck, and the gastrointestinal tract. The article describes a rare clinical case of congenital IF of soft tissues of the chest wall in a newborn, as well as a literature review.


  • Open Access

    Congenital mesoblastic nephroma. Own experience of the Research Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia

    by G. B. Sagoyan, M. V. Rubanskaya, D. V. Shevtsov, M. A. Rubanskiy, P. A. Kerimov, А. M. Suleymanova, R. I. Pimenov, A. S. Temnyy, O. A. Kirillova, E. V. Zakharova, et al.

    Врожденная мезобластная нефрома. Собственный опыт НИИ детской онкологии и гематологии ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России

  • Open Access

    CRYO PRESERVATION OF HUMAN DENDRITIC CELLS FOR CLINICAL USE

    by G. Z. Chkadua, A. A. Borunova, I. B. Shoua, I. S. Dolgopolov, R. I. Pimenov, I. N. Mikhailova, T. N. Zabotina, M. A. Baryshnikova

    Introduction. The increasing clinical use of cellular technologies suggests the possibility of long-term storage of the cellular product while maintaining its viability and basic properties. The procedures of cell’s cryopreservation used in laboratory as well in clinical practice differ a lot. Each method includes two tasks to solve: what is the optimal freezing medium to use and what cryopreservation procedure to prefer. In this paper, we present the method utilized in our center for bone marrow cell cryopreservation. The freezing was carried out in nitrogen vapor after adding the medium containing 95 % dextran [average mw 50 000–70 000] and 5 % dimethylsulfoxid.Purpose. To show that the proposed method of cryopreservation of dendritic cells is highly effective, simple, reproducible and most convenient for clinical use.Materials and methods. Viability, expression of surface antigens and stimulating activity towards allogeneic T lymphocytes of cryopreserved mature dendritic cells cultured from peripheral blood monocytes were evaluated.Results. The first cryopreservation resulted in the death of a small amount of cells. The second freezing procedure increased the proportion of dead cells. Meanwhile, the difference in the expression of the surface antigens in fresh, cryopreserved and re-cryopreserved dendritic cells was not statistically significant. The level of stimulating activity of fresh and cryopreserved dendritic cells did not significantly differ. Conversely the proliferation of allogeneic T lymphocytes was decreased after stimulation with re-cryopreserved dendritic cells.Conclusion. The presented method of cryopreservation allows to preserve the viability and basic functions of dendritic cells. After thawing dendritic vaccine could be administered to patients after being diluted in an isotonic saline without washing, which makes this method the most convenient for clinical use.


  • Open Access

    Quality of life and psychological status of thoracic and abdominal pediatric cancer survivors

    by Svetlana N. Mikhailova, Olga V. Sachuk, Elena N. Sukhanovskaya, Timur T. Valiev, Anatolii P. Kazantsev, Marina V. Rubanskaya, Roman I Pimenov, Alina A Malakhova, Ekaterina S. Babij

    Relevance. The integrated approach in the treatment of malignant tumors in the chest or abdomen combined with achievements of surgery, chemotherapy and accompanying therapy significantly increased survival rate and recovery in paediatric patients and then specialists faced the new challenge - to improve indicators of the quality of life (QOL) in cured patients. The aim. To study indicators of the QOL and psychological characteristics of personality development in patients cured in childhood of tumors in the chest or abdomen. Materials and methods. The study included 184 patient aged between 8 and 18 years, cured of tumors in the chest or abdomen in RAMS N.N.Blokhin RCRC Pediatric Oncology and Hematology Research Institute of Ministry of Health of Russia from 1979 to 2015. The follow-up period was 3-25 years after the end of the complex antitumor treatment. The QOL analysis was held in 92 (50%) of patients. The QOL analysis was performed according to the examining children’s questioning in the PedsQL questionary. In addition, we assessed the psychological state and social adaptation measures in patients cured of tumors in the chest or abdomen. Results. The analysis demonstrated the reduction of the indicators of the QOL and psychosocial adaptation in patients cured of tumors in the chest or abdomen. Most often the reduction of adaptation occurred in adolescents (78%). We marked the increase in the frequency of medical care encounters of non-oncological profile, the decrease in cognitive function, hypererethism, indecisiveness and low self-confidence. Conclusions. We showed guidelines for the individual rehabilitation of patients cured of tumors in the chest or abdomen: sanatorium resort therapy, psychocorrective work, psychological rehabilitation for family of the patient.

  • Open Access

    Prophylactic thyroidectomy results among RET germline mutation bearers in families with hereditary forms of medullary thyroid cancer

    by Vladimir G. Polyakov, Ruslan V. Shishkov, Aleksei A. Ilyin, Severskaya N. Viktorovna, Natalia V. Ivanova, Roman I. Pimenov, Valentina M. Kozlova, Faina A. Amosenko, Ludmila N. Lubchenko, Tatyiana P. Kazubskaya, et al.

    Genetically caused medullary thyroid cancer (MTC) is associated with unfavorable survival prognosis, so it makes necessary to develop new diagnostic techniques to reveal pre-clinical stage of disease as well as to introduce into clinical practice the effective method of tumor prevention. The article represents first in Russia summary clinical experience of prophylactic thyroidectomy have been executed in the period 1998 – 2015 yeas among ten bearers of RET gene germlinemutation in families with hereditary disease including syndrome MEN2A and familial MTC. Aim: to evaluate the results of surgical treatment of asymptomatic carriers of germinal mutations in the RET gene. Materials and methods. In the period from 1998 to 2015, in two centers: N.N. Blokhin Russian Cancer Research Center, Moscow and A. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre, Obninsk was conducted prophylactic surgical treatment in 10 patients – asymptomatic carriers of germinal mutations in RET. Age of patients – from 2 to 23 years old. 9 patients – from families with the syndrome of multiple endocrineneoplasia type 2A (MEN2A), one – with the family of MTC. According to genealogy in 9 families of patients there have been cases of death from MTC or pheochromocytoma (PC). In all cases, surgical treatment was performed in a volume of TE, two patients additionally performed lymph node dissection VI level. The observation period after surgery ranged from 6 months to 16 years. Results. DNA diagnostics in 8 patients identified a mutation in exon 11, in one case – in exon 10 and one patient had revealed two mutations in exons 13 and 14. The age of patients ranged from 2 to 23 years. Basal calcitonin level was elevated in 7 of 10 patients. Such prophylactic TE in 2 patients was supplemented by selective lymph node dissection. Histological examination of the removal of the thyroid gland (TG) revealed foci of medullary cancer in 6 of 10. At 2 patients revealed a C-cell hyperplasia and at 2 patients were found signs of the well expressed and weakly expressed sclerosis in thyroid tissue. The earliest age to identify MTC was a child 3 years old, mutations in codon 634, from a family where relatives observed for aggressive MTC. In the course of follow-recurrence was detected in one patient, a child of 15 years, a similar mutation carrier. Conclusion. In view of the risk of MTC developing identifying a mutation in RET gene and preventive TE should be carried out as soon as possible. The high risk of MTC developing in RET-gene positive subjects was confirmed in this study (6 cases of cancer from 10 patients).


  • Open Access

    SOLID PSEUDOPAPILLARY PANCREATIC TUMORS IN PEDIATRIC PATIENTS: LITERATURE REVIEW

    by P. A. Kerimov, A. P. Kazantsev, M. A. Rubansky, M. V. Rubanskaya, R. I. Pimenov, O. A. Kapkova, D. V. Rybakova, Array В. Хижников, Array А. Рубанский

    СОЛИДНО-ПСЕВДОПАПИЛЛЯРНАЯ ОПУХОЛЬ ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ У ПАЦИЕНТОВ ДЕТСКОГО ВОЗРАСТА: ОБЗОР ЛИТЕРАТУРЫ